Enzyme-resistant immunomodulatory peptides
US4505853A · kind A · utility
40Cited by
4References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 1983 |
| Grant date | Mar 19, 1985 |
| Priority date | — |
| Expiry date | Nov 18, 2003 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides which have thymopoeitin-like or splenin-like activity combined with greatly increased resistance to degradation by enzymes. The peptides are useful for treatment of immunoregulatory disorders. Also provided are methods of treating immunoregulatory disorders and compositions used in these methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.